MedTrace Logo

The Tilburg Vasospasm Study

NCT01407614 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2011-08-02

No results posted yet for this study

Summary

In a prospective randomized controlled trial, the investigators aim to assess whether external lumbar drainage (ELD) of CSF is safe and reduces delayed cerebral ischemia and its sequelae in patients with an aneurysmal subarachnoid hemorrhage.

Conditions

  • Brain Ischemia
  • Intracranial Vasospasm

Interventions

PROCEDURE

external lumbar drainage (ELD) of cerebrospinal fluid

Patients were randomized for external lumbar drainage of cerebrospinal fluid or standard treatment of a subarachnoid hemorrhage alone. External drainage was started within 96 hours of initial subarachnoid hemorrhage during 7 days at a maximum of 5-10 ml/hour.

Sponsors & Collaborators

  • Elisabeth-TweeSteden Ziekenhuis

    lead OTHER

Principal Investigators

  • Paul Depauw, MD · Elisabeth-TweeSteden Ziekenhuis

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2009-03-31
Completion
2009-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01407614 on ClinicalTrials.gov